Interferon-γ release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients

Kevin Winthrop, Melissa Nyendak, Helene Calvet, Peter Oh, Melanie Lo, Gwendolyn Swarbrick, Carol Johnson, Deborah Lewinsohn, David Lewinsohn, Gerald H. Mazurek

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Background and objectives: End-stage renal disease (ESRD) patients are at high risk for tuberculosis (TB). IFN-γ release assays that assess immune responses to specific TB antigens offer potential advantages over tuberculin skin testing (TST) in screening such patients for Mycobacterium tuberculosis infection. This study sought to determine whether IFN-γ release assay results are more closely associated with recent TB exposure than TST results. Design, setting, participants, and measures: Prospective cohort investigation of patients at a hemodialysis center with a smear-positive case of TB. Patients without a history of TB underwent initial and repeat testing with TST, and with the IFN-γ assays QuantiFERON-TB Golde® (QFT-G) and ELISPOT test. Outcome measures included the prevalence of positive test results, identification of factors associated with positive results, and test result discordance. Results: A total of 100 (47% foreign born; median age, 55 yr; age range, 18 to 83 yr) of 124 eligible patients were enrolled. Twenty-six persons had positive TST results, 21 had positive QFT-G results, and 27 had positive ELISPOT results. Patients with TB case contact were likely to have a positive QFT-G result (P = 0.02) and ELISPOT results (P = 0.04), whereas TB case contact was not associated with positive TST results (P = 0.7). Positive TST results were associated with foreign birth (P = 0.04) and having had a TST in the previous year (P = 0.04). Conclusions: Positive IFN-γ assay results were more closely associated with recent TB exposure than were positive TST results. QFT-G and ELISPOT might offer a better method for detecting TB infection in ESRD patients.

Original languageEnglish (US)
Pages (from-to)1357-1363
Number of pages7
JournalClinical Journal of the American Society of Nephrology
Volume3
Issue number5
DOIs
StatePublished - Sep 2008

Fingerprint

Mycobacterium Infections
Mycobacterium tuberculosis
Interferons
Tuberculin
Renal Dialysis
Tuberculosis
Enzyme-Linked Immunospot Assay
Skin
Chronic Kidney Failure
Outcome Assessment (Health Care)
Parturition
Antigens

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Interferon-γ release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. / Winthrop, Kevin; Nyendak, Melissa; Calvet, Helene; Oh, Peter; Lo, Melanie; Swarbrick, Gwendolyn; Johnson, Carol; Lewinsohn, Deborah; Lewinsohn, David; Mazurek, Gerald H.

In: Clinical Journal of the American Society of Nephrology, Vol. 3, No. 5, 09.2008, p. 1357-1363.

Research output: Contribution to journalArticle

Winthrop, Kevin ; Nyendak, Melissa ; Calvet, Helene ; Oh, Peter ; Lo, Melanie ; Swarbrick, Gwendolyn ; Johnson, Carol ; Lewinsohn, Deborah ; Lewinsohn, David ; Mazurek, Gerald H. / Interferon-γ release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. In: Clinical Journal of the American Society of Nephrology. 2008 ; Vol. 3, No. 5. pp. 1357-1363.
@article{f9bda4dc8dbf4792a6a8757e60ad7287,
title = "Interferon-γ release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients",
abstract = "Background and objectives: End-stage renal disease (ESRD) patients are at high risk for tuberculosis (TB). IFN-γ release assays that assess immune responses to specific TB antigens offer potential advantages over tuberculin skin testing (TST) in screening such patients for Mycobacterium tuberculosis infection. This study sought to determine whether IFN-γ release assay results are more closely associated with recent TB exposure than TST results. Design, setting, participants, and measures: Prospective cohort investigation of patients at a hemodialysis center with a smear-positive case of TB. Patients without a history of TB underwent initial and repeat testing with TST, and with the IFN-γ assays QuantiFERON-TB Golde{\circledR} (QFT-G) and ELISPOT test. Outcome measures included the prevalence of positive test results, identification of factors associated with positive results, and test result discordance. Results: A total of 100 (47{\%} foreign born; median age, 55 yr; age range, 18 to 83 yr) of 124 eligible patients were enrolled. Twenty-six persons had positive TST results, 21 had positive QFT-G results, and 27 had positive ELISPOT results. Patients with TB case contact were likely to have a positive QFT-G result (P = 0.02) and ELISPOT results (P = 0.04), whereas TB case contact was not associated with positive TST results (P = 0.7). Positive TST results were associated with foreign birth (P = 0.04) and having had a TST in the previous year (P = 0.04). Conclusions: Positive IFN-γ assay results were more closely associated with recent TB exposure than were positive TST results. QFT-G and ELISPOT might offer a better method for detecting TB infection in ESRD patients.",
author = "Kevin Winthrop and Melissa Nyendak and Helene Calvet and Peter Oh and Melanie Lo and Gwendolyn Swarbrick and Carol Johnson and Deborah Lewinsohn and David Lewinsohn and Mazurek, {Gerald H.}",
year = "2008",
month = "9",
doi = "10.2215/CJN.01010208",
language = "English (US)",
volume = "3",
pages = "1357--1363",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "5",

}

TY - JOUR

T1 - Interferon-γ release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients

AU - Winthrop, Kevin

AU - Nyendak, Melissa

AU - Calvet, Helene

AU - Oh, Peter

AU - Lo, Melanie

AU - Swarbrick, Gwendolyn

AU - Johnson, Carol

AU - Lewinsohn, Deborah

AU - Lewinsohn, David

AU - Mazurek, Gerald H.

PY - 2008/9

Y1 - 2008/9

N2 - Background and objectives: End-stage renal disease (ESRD) patients are at high risk for tuberculosis (TB). IFN-γ release assays that assess immune responses to specific TB antigens offer potential advantages over tuberculin skin testing (TST) in screening such patients for Mycobacterium tuberculosis infection. This study sought to determine whether IFN-γ release assay results are more closely associated with recent TB exposure than TST results. Design, setting, participants, and measures: Prospective cohort investigation of patients at a hemodialysis center with a smear-positive case of TB. Patients without a history of TB underwent initial and repeat testing with TST, and with the IFN-γ assays QuantiFERON-TB Golde® (QFT-G) and ELISPOT test. Outcome measures included the prevalence of positive test results, identification of factors associated with positive results, and test result discordance. Results: A total of 100 (47% foreign born; median age, 55 yr; age range, 18 to 83 yr) of 124 eligible patients were enrolled. Twenty-six persons had positive TST results, 21 had positive QFT-G results, and 27 had positive ELISPOT results. Patients with TB case contact were likely to have a positive QFT-G result (P = 0.02) and ELISPOT results (P = 0.04), whereas TB case contact was not associated with positive TST results (P = 0.7). Positive TST results were associated with foreign birth (P = 0.04) and having had a TST in the previous year (P = 0.04). Conclusions: Positive IFN-γ assay results were more closely associated with recent TB exposure than were positive TST results. QFT-G and ELISPOT might offer a better method for detecting TB infection in ESRD patients.

AB - Background and objectives: End-stage renal disease (ESRD) patients are at high risk for tuberculosis (TB). IFN-γ release assays that assess immune responses to specific TB antigens offer potential advantages over tuberculin skin testing (TST) in screening such patients for Mycobacterium tuberculosis infection. This study sought to determine whether IFN-γ release assay results are more closely associated with recent TB exposure than TST results. Design, setting, participants, and measures: Prospective cohort investigation of patients at a hemodialysis center with a smear-positive case of TB. Patients without a history of TB underwent initial and repeat testing with TST, and with the IFN-γ assays QuantiFERON-TB Golde® (QFT-G) and ELISPOT test. Outcome measures included the prevalence of positive test results, identification of factors associated with positive results, and test result discordance. Results: A total of 100 (47% foreign born; median age, 55 yr; age range, 18 to 83 yr) of 124 eligible patients were enrolled. Twenty-six persons had positive TST results, 21 had positive QFT-G results, and 27 had positive ELISPOT results. Patients with TB case contact were likely to have a positive QFT-G result (P = 0.02) and ELISPOT results (P = 0.04), whereas TB case contact was not associated with positive TST results (P = 0.7). Positive TST results were associated with foreign birth (P = 0.04) and having had a TST in the previous year (P = 0.04). Conclusions: Positive IFN-γ assay results were more closely associated with recent TB exposure than were positive TST results. QFT-G and ELISPOT might offer a better method for detecting TB infection in ESRD patients.

UR - http://www.scopus.com/inward/record.url?scp=53749094028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53749094028&partnerID=8YFLogxK

U2 - 10.2215/CJN.01010208

DO - 10.2215/CJN.01010208

M3 - Article

C2 - 18550653

AN - SCOPUS:53749094028

VL - 3

SP - 1357

EP - 1363

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

SN - 1555-9041

IS - 5

ER -